“The SIA acquisition will provide us A further move nearer to achieving our ambition of starting to be a worldwide segment chief and innovator in breast reconstruction with foreseeable future FDA approvals, financial investment in pipeline and evidence era,” reported Jan De Witte, president and CEO, Integra LifeSciences.The corporation has actu